You just read:

Aralez Announces U.S. Commercial Launch Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

News provided by

Aralez Pharmaceuticals Inc.

03 Oct, 2016, 07:00 ET